Verici DX

(VRCI)
Sector: Pharmaceuticals & Biotechnology
3.31p
-0.07p -1.96
Last updated: 10:50:00

Director dealings

Trade date Director Volume / Price Trade value Trade type
03/11/2020 Ian James Carruthers 0 @ 0.00 0.00 Notification of Holding
03/11/2020 Barbara Therese Murphy 0 @ 0.00 0.00 Notification of Holding
03/11/2020 James Renwick McCullough 0 @ 0.00 0.00 Notification of Holding
03/11/2020 Julian Baines 0 @ 0.00 0.00 Notification of Holding

Director shareholdings

Name Holding Percent
James Renwick McCullough 2,870,110 2.00%
Julian Baines 1,381,236 1.00%
Barbara Therese Murphy 150,800 0.00%
Ian James Carruthers 100,000 0.00%

Major shareholders

Institution name Holding Percent
Harwood Capital Management 37,646,569 15.52%
Christopher Mills 23,722,501 16.70%
Octopus Investments Limited 21,645,096 8.92%
Icahn School of Medicine at Mount Sinai 19,501,330 11.40%
Mount Sinai 18,427,216 13.00%
Amati Global Investors Limited 15,111,111 6.23%
Renalytix 9,831,681 5.80%
EKF Diagnostics Holdings Plc 9,820,838 5.77%
Unicorn Asset Management Limited 9,239,660 5.43%
Canaccord Genuity Group Inc 8,239,314 4.80%